However, the inhibition of CRNDE in naïve CD8 + T cells can enhance the cytotoxicity of effector CD8 + T lymphocytes against cancer cells by inducing miR-545-5p and downregulating Tim-3 [254]. This evidence concerns the gene HAVCR2 and cancer.